HLS Therapeutics (TSE:HLS) Trading 0.8% Higher – Here’s What Happened

HLS Therapeutics Inc. (TSE:HLS) was up 0.8% during trading on Friday . The company traded as high as C$4.99 and last traded at C$4.99. Approximately 5,000 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 13,412 shares. The stock had previously closed at C$4.95.

Wall Street Analysts Forecast Growth

Separately, Raymond James Financial raised shares of HLS Therapeutics from a “hold” rating to a “moderate buy” rating and boosted their price target for the company from C$5.00 to C$6.00 in a research report on Thursday, August 21st. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, HLS Therapeutics currently has a consensus rating of “Hold” and an average price target of C$5.00.

HLS Therapeutics Stock Up 0.8%

The business’s fifty day moving average price is C$5.25 and its 200 day moving average price is C$5.18. The company has a quick ratio of 1.01, a current ratio of 1.56 and a debt-to-equity ratio of 86.50. The firm has a market capitalization of C$156.06 million, a PE ratio of -11.09 and a beta of 0.40.

HLS Therapeutics (TSE:HLS) last released its quarterly earnings results on Thursday, November 13th. The company reported C($0.12) earnings per share (EPS) for the quarter. The company had revenue of C$18.81 million for the quarter. HLS Therapeutics had a negative return on equity of 25.27% and a negative net margin of 38.70%. On average, equities research analysts forecast that HLS Therapeutics Inc. will post -0.12 earnings per share for the current fiscal year.

About HLS Therapeutics

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris.